Apollo Care SEMAGLUTIDE 20mg Vial Recall: Particulate Matter Hazard

✎ GovInfoNow plain-language explainer

What happened, in plain English

Apollo Care is recalling 20mg SEMAGLUTIDE vials that contain particulate matter, which could cause injection site reactions. This recall affects patients using these vials for weight management treatment.

Why it’s dangerous

The vials contain small particles of nylon/polyamide and silk/proteinaceous material. These particles could cause injection site reactions when administered subcutaneously.

Who’s affected

Patients using Apollo Care's SEMAGLUTIDE 20mg vials for weight management treatment. Those with specific NDC and lot numbers are most at risk.

How to tell if you have this one

Check for NDC 71170-724-04 with lots AC-017275 (exp. 12/13/2026) or AC-017282, AC-017285 (exp. 12/27/2026). The vials are prescription-only for subcutaneous injection.

Brand
Apollo Care
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Vial Details
Verify the NDC number and lot numbers listed in the recall notice to confirm if your vial is affected.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates the presence of particulate matter that could cause injection site reactions, so it is not safe to use.

What should I do if I have this vial?

The recall does not specify a remedy, so contact Apollo Care directly for guidance.

How can I tell if my vial is affected?

Check for NDC 71170-724-04 with lots AC-017275 (exp. 12/13/2026) or AC-017282, AC-017285 (exp. 12/27/2026).

Take action

Contact Apollo Care

We’ve drafted a message you can send Apollo Care to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0757-2026 — Apollo Care Apollo Care

Hello,

I own a Apollo Care that is covered by recall D-0757-2026 from Apollo Care.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0757-2026 (July 29, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0757-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 27, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Apollo Care, LLC recalls SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection

Lower-risk recall